Inpatient Mortality Benefit with Transjugular Intrahepatic Portosystemic Shunt for Hospitalized Hepatorenal Syndrome Patients

Related medical research illustration

Overview

Analysis of inpatient mortality outcomes in patients with hepatorenal syndrome treated with TIPS.

Publication Details

**Journal:** Digestive Diseases and Sciences

**Year:** 2020

**Authors:** Charilaou P, Devani K, Petrosyan R, Reddy C, Pyrsopoulos N

**PMID:** 32062714

**DOI:** 10.1007/s10620-020-06136-2

Key Findings

This publication contributes to the field of gastroenterology and hepatology, providing valuable insights into renal function. The research methodology and findings offer important implications for clinical practice and patient care.

Clinical Significance

The findings from this study have significant implications for:

- Clinical decision-making in gastroenterology

- Patient care and treatment protocols

- Future research directions in the field

Access the Full Publication

For the complete research article, detailed methodology, and comprehensive results, please refer to the original publication.

This blog post summarizes a peer-reviewed publication by Dr. Kalpit Devani and colleagues. For detailed information, please refer to the original publication.